Results 31 to 40 of about 83,602 (280)

GO analysis for differential mRNAs in the competing endogenous RNA network. [PDF]

open access: yes, 2021
GO analysis for differential mRNAs in the competing endogenous RNA network.
Tao-Lin Xia (11790741)   +4 more
core   +1 more source

GO and KEGG analysis involving DE-mRNAs in the lncRNA/circRNA-miRNA-mRNA competing endogenous RNA network. [PDF]

open access: yes, 2022
(A) The top 30 GO terms of DE-mRNAs in the lncRNA-miRNA-mRNA competing endogenous RNA network, including MF, CC and BP classification. The horizontal axis is the enrichment value of functional degree, and the vertical axis is the entry name corresponding
Na Li (6550)   +5 more
core   +1 more source

The top 15 nodes in the competing endogenous RNA (ceRNA) regulatory network in the blue module and the turquoise module. [PDF]

open access: yes, 2022
The top 15 nodes in the competing endogenous RNA (ceRNA) regulatory network in the blue module and the turquoise module.
Ren-Dong Xiao (12878506)   +5 more
core   +1 more source

MiR-96 induced non-small-cell lung cancer progression through competing endogenous RNA network and affecting EGFR signaling pathway [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2019
Objective(s): Non-small cell lung cancer (NSCLC) has become a serious global health problem in the 21st century, and tumor proliferation and metastasis are the leading causes of death in patients  with lung cancer.
Hao Ding   +5 more
doaj   +1 more source

Image5_A Novel Competing Endogenous RNA Network Associated With the Pathogenesis of Graves’ Ophthalmopathy.TIFF [PDF]

open access: yes, 2021
Background: Growing evidence has recently revealed the characteristics of long noncoding (lncRNA)/circular RNA (circRNA)-microRNA (miRNA)-mRNA networks in numerous human diseases. However, a scientific lncRNA/circRNA-miRNA-mRNA network related to Graves’
Ruili Wei (848963)   +4 more
core   +1 more source

Table2_A Novel Competing Endogenous RNA Network Associated With the Pathogenesis of Graves’ Ophthalmopathy.XLSX [PDF]

open access: yes, 2021
Background: Growing evidence has recently revealed the characteristics of long noncoding (lncRNA)/circular RNA (circRNA)-microRNA (miRNA)-mRNA networks in numerous human diseases. However, a scientific lncRNA/circRNA-miRNA-mRNA network related to Graves’
Ruili Wei (848963)   +4 more
core   +1 more source

Image2_A Novel Competing Endogenous RNA Network Associated With the Pathogenesis of Graves’ Ophthalmopathy.TIF [PDF]

open access: yes, 2021
Background: Growing evidence has recently revealed the characteristics of long noncoding (lncRNA)/circular RNA (circRNA)-microRNA (miRNA)-mRNA networks in numerous human diseases. However, a scientific lncRNA/circRNA-miRNA-mRNA network related to Graves’
Ruili Wei (848963)   +4 more
core   +1 more source

A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia

open access: yesFrontiers in Oncology, 2020
BackgroundAcute myeloid leukemia (AML) is a genetically, biologically and clinically heterogeneous hematopoietic malignancy that is highly dependent on the bone marrow (BM) microenvironment.
Shujuan Wang   +7 more
doaj   +1 more source

Image4_A Novel Competing Endogenous RNA Network Associated With the Pathogenesis of Graves’ Ophthalmopathy.TIFF [PDF]

open access: yes, 2021
Background: Growing evidence has recently revealed the characteristics of long noncoding (lncRNA)/circular RNA (circRNA)-microRNA (miRNA)-mRNA networks in numerous human diseases. However, a scientific lncRNA/circRNA-miRNA-mRNA network related to Graves’
Ruili Wei (848963)   +4 more
core   +1 more source

Table8_A Novel Competing Endogenous RNA Network Associated With the Pathogenesis of Graves’ Ophthalmopathy.XLSX [PDF]

open access: yes, 2021
Background: Growing evidence has recently revealed the characteristics of long noncoding (lncRNA)/circular RNA (circRNA)-microRNA (miRNA)-mRNA networks in numerous human diseases. However, a scientific lncRNA/circRNA-miRNA-mRNA network related to Graves’
Ruili Wei (848963)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy